Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medplus Health ServicesNSE:MEDPLUS -1.37%76 Return-on-Tangible-Asset is 3.42% as of Jun. 2026, which is 0% above its 10-year median of 3.41. GuruFocus rates NSE:MEDPLUS with a GF Score™ of 76/100 and a GF Value™ of ₹962.14 (Modestly Undervalued). Among 679 Healthcare Providers & Services companies, Medplus Health Services ranks better than 67.01% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Medplus Health Services's annualizedNet Income for the quarter that ended in Jun. 2026 was ₹1,327 Mil. Medplus Health Services's average total tangible assets for the quarter that ended in Jun. 2026 was ₹38,832 Mil. Therefore, Medplus Health Services's annualized Return-on-Tangible-Asset for the quarter that ended in Jun. 2026 was 3.42%.
The historical rank and industry rank for Medplus Health Services's Return-on-Tangible-Asset or its related term are showing as below:
NSE:MEDPLUS'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 0.2 Med: 3.41 Max: 6.11
Current: 5.89
During the past 8 years, Medplus Health Services's highest Return-on-Tangible-Asset was 6.11%. The lowest was 0.20%. And the median was 3.41%.
NSE:MEDPLUS's Return-on-Tangible-Asset is ranked better than 67.01% of 679
companies
in the Healthcare Providers & Services industry
Industry Median: 2.51
vs NSE:MEDPLUS: 5.89
Medplus Health Services (NSE:MEDPLUS) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Medplus Health Services Return-on-Tangible-Asset Related Terms
Medplus Health Services Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Medplus Health Services's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medplus Health Services Return-on-Tangible-Asset Chart
Medplus Health Services Return-on-Tangible-Asset Competitor Comparison
For the Pharmaceutical Retailers subindustry, Medplus Health Services's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medplus Health Services Return-on-Tangible-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Medplus Health Services's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Medplus Health Services's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Jun. 2026) net income data.
What does a Return-on-Tangible-Asset of 3.42% mean?
Medplus Health Services (NSE:MEDPLUS) has a Return-on-Tangible-Asset of 3.42% as of Jun. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Medplus Health Services and its competitors. This is near median its historical median of 3.41. Over the past decade, Medplus Health Services' Return-on-Tangible-Asset has ranged from 0.20 to 6.11. According to the industry distribution chart, Medplus Health Services ranks #224 out of 679 companies in the Healthcare Providers & Services industry, placing it in the top 33%.
Is Medplus Health Services' Return-on-Tangible-Asset too high?
Medplus Health Services' current Return-on-Tangible-Asset of 3.42% is near median its 10-year median of 3.41. Over the past 10 years, this metric has ranged from a low of 0.20 to a high of 6.11. The Healthcare Providers & Services industry median Return-on-Tangible-Asset is 2.51. Medplus Health Services' value of 3.42% is 36.3% above this industry median. Based on the distribution chart, Medplus Health Services ranks #224 out of 679 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Medplus Health Services has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medplus Health Services' Return-on-Tangible-Asset compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Medplus Health Services ranks #224 out of 679 companies for Return-on-Tangible-Asset. This puts Medplus Health Services in the upper half of its industry. The industry median Return-on-Tangible-Asset is 2.51. Medplus Health Services' value of 3.42% is 36.3% above this benchmark. Historically, Medplus Health Services' own Return-on-Tangible-Asset has ranged from 0.20 to 6.11 over the past decade. While the company's 10-year median is 3.41 vs. the industry median of 2.51, Medplus Health Services has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Healthcare Providers & Services company?
The median Return-on-Tangible-Asset among Healthcare Providers & Services companies is 2.51, based on 679 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medplus Health Services's current Return-on-Tangible-Asset of 3.42% is 36.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Medplus Health Services and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Asset is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medplus Health Services's current Return-on-Tangible-Asset is 3.42%, which is near median its own 10-year median of 3.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medplus Health Services stock overvalued right now?
Based on GuruFocus' analysis, Medplus Health Services (NSE:MEDPLUS) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹962.14, compared to a current price of ₹704.95 — trading 26.7% below its estimated fair value. The current Return-on-Tangible-Asset is 3.42%, which is near median its 10-year median of 3.41 and 36.3% above the Healthcare Providers & Services industry median of 2.51. Medplus Health Services' overall GF Score™ is 76/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Medplus Health Services (NSE:MEDPLUS), the current Return-on-Tangible-Asset is 3.42% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medplus Health Services (NSE:MEDPLUS) Overvalued in 2026?
Based on GuruFocus' analysis, Medplus Health Services stock appears to be undervalued.
The current stock price of ₹704.95 is trading 26.7% below its estimated GF Value™ of ₹962.14.
GuruFocus considers Medplus Health Services to be Modestly Undervalued.
Key valuation signals for NSE:MEDPLUS:
Return-on-Tangible-Asset: 3.42% (near median its 10-year median of 3.41)
GF Value™: ₹962.14 vs. price of ₹704.95 (26.7% below fair value)
Industry Position: 36.3% above the Healthcare Providers & Services median (#224 of 679)
No single metric tells the full story. See the NSE:MEDPLUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medplus Health Services Ltd is a pharmacy retailer. It offers pharmaceutical and wellness products such as medicines, vitamins, medical devices, test kits, and others. The company also offers an omnichannel platform wherein customers can purchase products through stores, place orders over the telephone, online orders, and a Click and Pick facility. Its operating segments include Retail, Diagnostics, and Others.
76GF Score
Get the complete analysis for NSE:MEDPLUS
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MEDPLUS has been successfully added to your 
